AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...

Q2 2026 Earnings Call Transcript January 6, 2026 AngioDynamics, Inc. misses on earnings expectations. Reported EPS is ...

AngioDynamics reported Q3 revenue of $79.4 million, up 8.8% year-over-year on a pro forma basis and higher than the consensus ...

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the ...

AngioDynamics ( ($ANGO) ) has provided an update. On January 6, 2026, AngioDynamics reported financial results for its fiscal second quarter ended ...

Moderated by Saleem Ahmed, associate editor of The Business Standard, the roundtable was attended by public officials, independent energy experts, development partners, and private-sector leaders.

Ionis Pharmaceuticals, Inc. partner GSK today announced positive results from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, evaluating the safety and efficacy of bepirovirsen, an investigational ...

COCOS, the globally renowned provider of game engines and development tools fully acquired by SUD, today announced the full ...

CES Tech Talk – Download and listen for the top trends expected at CES 2026. Exhibitor Examples: Aizip, AMD, DEEPX, LG ...

What Not To Miss at CES (R) 2026. The world's most powerful tech event, returns to Las Vegas, January 6-9.

NFL star players from different NFL Teams will autograph on-site up to 3,000 The Dream Bowl memorabilia items such as helmets, footballs, jerseys, and live-autographs by Notable Live.Autographed ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...